Adams Diversified Equity Fund’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-91,200
| Closed | -$13.9M | – | 117 |
|
|
2021
Q1 | $13.9M | Hold |
91,200
| – | – | 0.6% | 62 |
|
|
2020
Q4 | $14.2M | Hold |
91,200
| – | – | 0.64% | 59 |
|
|
2020
Q3 | $10.4M | Hold |
91,200
| – | – | 0.51% | 74 |
|
|
2020
Q2 | $10.2M | Buy |
+91,200
| New | +$10.2M | 0.54% | 69 |
|
|
2019
Q3 | – | Sell |
-146,700
| Closed | -$19.2M | – | 215 |
|
|
2019
Q2 | $19.2M | Hold |
146,700
| – | – | 1.02% | 36 |
|
|
2019
Q1 | $19.8M | Buy |
146,700
+39,500
| +37% | +$5.34M | 1.09% | 30 |
|
|
2018
Q4 | $10.4M | Hold |
107,200
| – | – | 0.64% | 64 |
|
|
2018
Q3 | $14.9M | Hold |
107,200
| – | – | 0.74% | 54 |
|
|
2018
Q2 | $13.3M | Hold |
107,200
| – | – | 0.71% | 57 |
|
|
2018
Q1 | $11.9M | Buy |
107,200
+33,800
| +46% | +$3.77M | 0.65% | 61 |
|
|
2017
Q4 | $8.78M | Hold |
73,400
| – | – | 0.47% | 76 |
|
|
2017
Q3 | $10.3M | Buy |
+73,400
| New | +$10.3M | 0.56% | 71 |
|